Apellis Pharmaceuticals' Series A - II Round

Apellis Pharmaceuticals raised a round of funding on July 25, 2012.

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases…

Articles about Apellis Pharmaceuticals' Series A - II Round: